| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 |
| filingDate |
2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5976e5b3dd2be1150da65007b3d0e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f711661d373fee24a20e92e5c8ddff1 |
| publicationDate |
2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014336108-A1 |
| titleOfInvention |
Compounds as tyrosine kinase modulators |
| abstract |
The present invention is directed to novel compounds of Formula I. The compounds of the present invention are potent tyrosine kinase modulators, and are suitable for the treatment and prevention of diseases and conditions related to abnormal activities of tyrosine kinase receptors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11466027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11358971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471455-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018211442-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016513092-A |
| priorityDate |
2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |